Variable | Priority Allocated | Â | DF | p | Chi-squared | Â | |||
---|---|---|---|---|---|---|---|---|---|
Age Groups | 1 | 2 | 3 |  | 4 | < 0.0001 | 41.328 |  | |
< 3 years | 83(10.8%) | 98(11.0%) | 114(19.7%) | 295 (13.2%) |  |  | |||
3–5 years | 454(59.1%) | 585(65.7%) | 340 (59.0%) | 1379 (61.7%) |  | ||||
> 5 years | 231(30.1) | 207(23.3%) | 123 (21.3) | 561 (25.1%) |  | ||||
Total (n) | 768 (34.4%) | 890 (39.8%) | 577 (25.8%) | 2235 | Â | ||||
CALD Status | 1 | 2 | 3 |  | 2 | < 0.0001 | 25.529 |  | |
CALD | 475(65.7%) | 560(69.5%) | 307(56.2%) | 1342 (64.7%) | Â | Â | |||
Not CALD | 248(34.3%) | 246(30.5%) | 239(43.8%) | 733 (35.3%) | Â | ||||
Total (n) | 723 (34.8%) | 806 (38.8%) | 546 (26.3%) | 2075 | Â | ||||
Level of Delay | 1 | 2 | 3 | Â | 6 | 0.008 | 17.529 | Â | |
Mild | 179(35.2%) | 231(36.8%) | 119(33.8%) | 529 (35.6%) | Â | Â | |||
Moderate | 160(31.5%) | 229(36.5%) | 133(37.8%) | 522 (35.1%) | Â | ||||
Severe | 85(16.7%) | 71(11.3%) | 55(15.6%) | 211 (14.2%) | Â | ||||
Profound Significant Borderline | 10(2.0%) 53(10.4%) 21(4.2%) | 2(0.3%) 61(9.7%) 33(5.3%) | 3 (0.9%) 34(9.7%) 8(2.2%) | 15 (1.0%) 148 (9.9%) 62 (4.2%) | Â | ||||
Total (n) | 508 (34.1%) | 627(42.2%) | 352 (23.7%) | 1487 | Â | ||||
Primary Diagnosis | 1 | 2 | 3 |  | 12 | < 0.0001 | 59.630 | ||
ASD | 204 (29.6%) | 149(18.9%) | 94(21.8%) | 447 (23.4%) | Â | Â | |||
ASD/GDD | 191(27.7%) | 207(26.2%) | 168(39.0%) | 566 (29.6%) | Â | ||||
Average | 41(6.0%) | 53(6.7%) | 18(4.2%) | 112 (5.9%) | Â | ||||
GDD | 207(30.0%) | 301(38.1%) | 124(28.8%) | 632 (33.1%) | Â | ||||
ID | 3(0.4%) | 8(1.0%) | 2(0.5%) | 13 (0.7%) | Â | ||||
Not Applicable | 26(3.8%) | 35(4.4%) | 17(3.9%) | 78 (4.1%) | Â | ||||
SLI | 17(2.5%) | 36(4.7%) | 8(1.8%) | 61 (3.2%) | Â | ||||
Total (n) | 689 (36.1%) | 789 (41.3%) | 431 (22.6%) | 1909 | Â |